Senate Debates Prescription Drug Imports Amendment to Health Care Plan

Washington -- The Senate's 10th straight day of debate on the healthcare reform bill focused on an amendment that some say could save Americans billions of dollars in prescription drug costs every year.

A bipartisan group of senators is pushing for an amendment that would allow U.S. pharmacies and drug wholesalers to import FDA-approved medications from Canada, Europe and other countries.

Even before the proposal hit the Senate floor, the FDA issued a letter saying it would be difficult to ensure the safety of imported drugs.

The pharmaceutical industry, which has spent millions in support of healthcare reform, stands to lose much more if Americans begin buying their medicines outside the U.S.

Lawmakers behind the proposal hope consumers' savings sway the vote.

Sen. Debbie Stabenow, (D) MI, said "It will help every family and every individual who needs medicine and is paying higher and higher prices every single year,"

One senator says one example of savings is the cholesterol lowering drug Lipitor, which costs 40 percent less in Canada.

The Obama administration has also spoke out against the plan.